ARMI - Advanced Regenerative Manufacturing Institute services
ARMI BioIndustries
Manufacturing Services
Producing the tissue-engineered, clinical trial material following a phase-appropriate, Quality-Management System.
Analytical Services
Deep cell and tissue characterization is essential to the development of controlled manufacturing processes for living, cell-based products. ARMI built a Deep Tissue Characterization Center (DTCC) to address this critical need. The DTCC applies a multiomic approach to characterizing cells, tissues, organs and materials. It correlates clinical outcomes to quality attributes and process parameters. And it applies Quality by Design principles to the development of scalable, consistent processes.
Regulatory Services
BioFabUSA
Technical Projects
BioFabUSA’s Technology Development Projects are intended to fill current manufacturing technology gaps. The solutions we develop are interoperable with each other, as well as existing technologies, enabling scalable, consistent and cost-effective manufacturing. Technical project calls and approved projects span the manufacturing process and crosscutting development areas from our technical roadmap.
BioFabUSA - Project Calls
Technical Project Calls Services
A major objective of ARMI | BioFabUSA’s technology strategy is to develop platform technologies to remove existing hurdles to scalable, consistent and cost-effective tissue manufacturing of cells, tissues and organs. It was developed to demonstrate advanced manufacturing for cells, tissues and organs, as well as to anchor the development, validation and demonstration of new technologies across ARMI | BioFabUSA’s crosscutting development areas.